FALCONS FORTUNES

Falcons' Fortunes - FACIT's Annual Pitch Competition - Friday, February 4, 2022

Falcons' Fortunes logo

 

 

 

 

 

 

 

 

Opportunity for Ontario Cancer Researchers to vie for the "Ernsting Entrepreneurship Award"

Hosted by FACIT, the annual Falcons' Fortunes pitch competition invites Ontario-based entrepreneurs working in the oncology space to pitch innovative research ideas to an external panel of judges. 

New for 2022: To continue to help fill Ontario's seed capital gap, the value of the prize has been increased to $100,000 from FACIT's Prospects Fund.

While the research idea must be novel and sound (and is subject to further due diligence after the event), the competition is for the best pitch i.e. the presentation that best convinces the investor judging panel on the value of the idea and how $100,000 would improve and/or better illustrate the potential, and if possible commercial, value of the innovative idea itself.

The Falcons’ Fortunes event endeavors to enhance, support and celebrate a culture of commercialization in Ontario, such as the cultivation of skill sets that enable ideas to be successfully pitched to investors and promotion of entrepreneurial spirit.

Eligibility:

The Falcons’ Fortunes pitch competition is open to any Ontario-based entrepreneurial researcher (e.g. academia, research institutions, research hospitals, startups, etc.) working in the oncology space. Basically, anyone with the entrepreneurial itch should participate!

How to participate:

Send an email to Lisa Milestone by Friday, November 19th, 2021 to indicate your intent to participate. An abstract of your pitch idea must be submitted by Friday, December 3rd, 2021 (instructions on submitting abstracts will be emailed to participants).  A maximum of 6 participants will be selected by Thursday, December 16th, 2021 to deliver their pitches on Friday, February 4th, 2022.

Format:

Selected participants will give 10-minute pitch presentations to the panel of investors, followed by 5-minutes of Q&A. The objective is to share your big picture idea and convince the panel that an investment of Prospects funding will contribute to moving the idea forward. The pitch should tell a story and highlight (at minimum):

  • The research idea and associated technology (what is it, what does it do)
  • The need or issue addressed (what is the problem)
  • The target audience/customer (addressable market)
  • What the investment will do to advance the idea (use of proceeds)
  • Commercial relevance of project (why is it commercially suited/important)
  • Any supporting data or relevant demo

Other additional considerations for the presentation (i.e. preparation for the Q&A) include an understanding of the market potential, IP position or challenges, and what areas of expertise are being sought that members of the investment panel may possess and could provide.

Support Available:

The FACIT team will provide pitch preparation resources leading up to the event.  

Summary of Timeline:

Notice of intent to participate - email RSVP sufficient Fri, Nov 19
Submission of pitch abstracts Fri, Dec 3
Announcement of selected pitch candidates Thurs, Dec 16
Pitch preparation webinar Wed, Jan 12
1:1 coaching sessions for finalists Mon, Jan 24
Brief run through of event for finalists Wed, Feb 2
Falcons' Fortunes event Fri, Feb 4

Questions?

For more details about the competition, please contact Lisa Milestone for more information.

Past Winners:

2021: Air compression sleeve for treating breast cancer-related lymphedema

Air Microfluidic Systems Inc. is developing an air microfluidics-enabled active compression sleeve for treating breast cancer-related lymphedema. 

 

2021: Air compression sleeve for treating breast cancer-related lymphedema2021: Air compression sleeve for treating breast cancer-related lymphedema


2020: Scaling clinical expertise with AI to automate and improve the delivery of cancer care

Bridge7 uses AI to automate & improve the efficiency, consistency & quality of delivering cancer care. Bridge7 has commercialized the first automated treatment planning solution being used clinically. 

 

2020: Scaling clinical expertise with AI to automate and improve the delivery of cancer care2020: Scaling clinical expertise with AI to automate and improve the delivery of cancer care


2019: A radially expandable access port to maximize the potential of laparoscopic surgical oncology

Recognizing a real unmet need, Xpan is developing expandable surgical access ports that aim to increase safety and efficiency of minimally invasive surgeries.

 

2019: A radially expandable access port to maximize the potential of laparoscopic surgical oncology2019: A radially expandable access port to maximize the potential of laparoscopic surgical oncology


2018: ReFilx™ – A regenerative filler matrix for breast cancer patients

ReFilx™ is a novel polymeric soft tissue filler that provides breast cancer patients with a cosmetically superior, minimally-invasive and cost-effective solution for the permanent restoration of breast defects following lumpectomy.

2018: ReFilx™ – A regenerative filler matrix for breast cancer patients2018: ReFilx™ – A regenerative filler matrix for breast cancer patients